InvestorsHub Logo
Followers 13
Posts 1812
Boards Moderated 0
Alias Born 03/29/2016

Re: AngeloFoca post# 22231

Friday, 01/20/2017 2:17:45 PM

Friday, January 20, 2017 2:17:45 PM

Post# of 38634
I've thought the same thing too. I thought Purdue was interested in IPCI platform. They knew they have to do something to protect their market. So it's either doing in house R&D or shop around.

If you look around how many companies are developing abuse deterrent tech? Not that many. The big pharma that have stuff approved is already competing against Purdue in the market. Not much choices left for the smaller developing companies that showed promise.

We might be right on here that FDA acceptance could mean a potential partnership with Purdue. Although acceptance doesn't mean approval but it at least establish the fact that FDA was happy with what IPCI presented to them for review.

I get the feeling Purdue is going to make a move in acquisition so it is wise to be holding companies like IPCI that has potential for a deal with Purdue or a take over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y